Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > $ 27.89 Billion Growth in Global Legal Cannabis Market
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(666)
•••
Post by proneon Feb 03, 2021 4:06pm
113 Views
Post# 32461561

$ 27.89 Billion Growth in Global Legal Cannabis Market

$ 27.89 Billion Growth in Global Legal Cannabis Market
 

 During 2020-2024 ....| Technavio

20 hours ago by Business Wire
...
 

Technavio announces the release of its latest report on the legal cannabis market.

The market is segmented by product (medical and recreational) and geography (APAC, Europe, MEA, North America, and South America).

The report offers an in-depth analysis of recent developments, changes in market regulations, product approvals, product launches, and the market behavior across various segments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210202006202/en/

$ 27.89 Billion Growth in Global Legal Cannabis Market During 2020-2024 | Featuring Key Vendors Including Aphria Inc., Aurora Cannabis Inc., and Bhang Corp. | Technavio

20 hours ago by Business Wire
Companies Mentioned: APHA
 

Technavio announces the release of its latest report on the legal cannabis market. The market is segmented by product (medical and recreational) and geography (APAC, Europe, MEA, North America, and South America). The report offers an in-depth analysis of recent developments, changes in market regulations, product approvals, product launches, and the market behavior across various segments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210202006202/en/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities